Assessment of serum total 25-hydroxyvitamin D assay commutability of Standard Reference Materials and College of American Pathologists Accuracy-Based Vitamin D (ABVD) Scheme and Vitamin D External Quality Assessment Scheme (DEQAS) materials: Vitamin D Standardization Program (VDSP) Commutability Study 2.

Johanna E Camara, Stephen A Wise,Andrew N Hoofnagle, Emma L Williams,Graham D Carter, Julia Jones,Carolyn Q Burdette, Grace Hahm, Federica Nalin, Adam J Kuszak,Joyce Merkel, Ramón A Durazo-Arvizu,Pierre Lukas,Étienne Cavalier, Christian Popp, Christian Beckert, Jan Schultess, Glen Van Slooten,Carole Tourneur, Camille Pease, Ravi Kaul, Alfredo Villarreal,Fiona Ivison,Ralf Fischer,Jody M W van den Ouweland, Chung S Ho, Emmett W K Law,Jean-Nicolas Simard,Renaud Gonthier, Brett Holmquist,Marcelo Cidade Batista, Heather Pham, Alex Bennett,Sarah Meadows, Lorna Cox,Eugene Jansen, Dilshad Ahmed Khan,Kimberly Robyak, Michael H Creer,Mark Kilbane, Patrick J Twomey,James Freeman,Neil Parker, Jinyun Yuan, Robert Fitzgerald,Sohail Mushtaq, Michael W Clarke,Norma Breen, Christine Simpson,Christopher T Sempos

Analytical and bioanalytical chemistry(2021)

引用 13|浏览13
暂无评分
摘要
An interlaboratory study was conducted through the Vitamin D Standardization Program (VDSP) to assess commutability of Standard Reference Materials® (SRMs) and proficiency testing/external quality assessment (PT/EQA) samples for determination of serum total 25-hydroxyvitamin D [25(OH)D] using ligand binding assays and liquid chromatography-tandem mass spectrometry (LC-MS/MS). A set of 50 single-donor serum samples were assigned target values for 25-hydroxyvitamin D2 [25(OH)D2] and 25-hydroxyvitamin D3 [25(OH)D3] using reference measurement procedures (RMPs). SRM and PT/EQA samples evaluated included SRM 972a (four levels), SRM 2973, six College of American Pathologists (CAP) Accuracy-Based Vitamin D (ABVD) samples, and nine Vitamin D External Quality Assessment Scheme (DEQAS) samples. Results were received from 28 different laboratories using 20 ligand binding assays and 14 LC-MS/MS methods. Using the test assay results for total serum 25(OH)D (i.e., the sum of 25(OH)D2 and 25(OH)D3) determined for the single-donor samples and the RMP target values, the linear regression and 95% prediction intervals (PIs) were calculated. Using a subset of 42 samples that had concentrations of 25(OH)D2 below 30 nmol/L, one or more of the SRM and PT/EQA samples with high concentrations of 25(OH)D2 were deemed non-commutable using 5 of 11 unique ligand binding assays. SRM 972a (level 4), which has high exogenous concentration of 3-epi-25(OH)D3, was deemed non-commutable for 50% of the LC-MS/MS assays.
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要